Achieving New Standards in the Treatment of Breast Cancer: Nuances of Optimal, Individualized, and Evidence-Based Patient Care

Activity Description & Educational Objectives

In this educational activity based on a recent live webcast, an expert uses challenging, real-world cases to provide guidance on best practices for devising individualized assessment and treatment plans for patients with breast cancer, while also highlighting the importance of effective transdisciplinary collaboration to ensure the best possible outcome. By blending discussions of patient scenarios with a review of current evidence, this educational activity elucidates key aspects of optimized care for patients with breast cancer in the modern era of personalized medicine and rapid clinical advances.

Upon completion of this activity, participants will be able to:

• Discuss the most recent efficacy and safety data related to different chemotherapeutic, hormonal, and molecularly targeted approaches to the treatment of breast cancer
• Demonstrate knowledge of the latest breast cancer practice guideline recommendations regarding patient and tumor assessment, individualized treatment selection and administration, and adequate monitoring and follow-up throughout the continuum of disease
• Employ proven patient and tumor assessment tools as guides for determining the best management plan for each individual patient with breast cancer
• Develop evidence-based, guideline-directed, individualized treatment plans for patients with breast cancer
• Establish interdisciplinary relationships with colleagues from other specialties to promote collaborative decision-making and continuity of care throughout the breast cancer disease continuum

Target Audience

This activity has been designed to meet the educational needs of medical and surgical oncologists, pathologists, oncology nurses, and other clinicians active or interested in the management of breast cancer.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: December 19, 2012 - December 18, 2013
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Moderator

Kathy D. Miller, MD
Associate Professor of Medicine
Sheila D. Ward Scholar
IU Simon Cancer Center
Indiana University School of Medicine
Indianapolis, Indiana

Kathy D. Miller, MD, has a financial interest/relationship or affiliation in the form of:

Consultant for Antigen Express, Inc. and Nektar Therapeutics.

Grant/Research Support from Clovis Oncology; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Geron; and Merrimack Pharmaceuticals Inc. to IU Simon Cancer Center.

Speakers Bureau participant with F. Hoffmann-La Roche Ltd and Genentech, Inc.

Advisory Board for Antigen Express, Inc.

CME Reviewer

Leah Cream, MD
Assistant Professor of Medicine
Hematology and Oncology Division
Penn State College of Medicine
Hershey, Pennsylvania

Leah Cream, MD, has a financial interest/relationship or affiliation in the form of:

Other Financial or Material Support from In the past 12 months, spouse was on Speakers Bureaus for Amgen Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; and Sanofi-Aventis.

Medical Director

Kadrin Wilfong, MD
PVI, PeerView Institute for Medical Education

Kadrin Wilfong, MD, currently has no financial interests/relationships or affiliations in relation to this activity.

Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.

Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5219-13-T.

Nurses

The Institute for Advancement of Human Behavior is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This course is co-provided by IAHB and PVI, PeerView Institute for Medical Education. Maximum of 1.0 contact hour(s).

This CME/CNE activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education; the activity is also co-provided by the Institute for Advancement of Human Behavior.

This activity is supported by educational grants from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.